Clinical Trial

Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease

Study acronym: CoStemCells
Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-01-26; most recent amendment 2025-08-26.
Status change: Not Yet Recruiting → Recruiting 2022-11-21
Trial Details
NCT Number NCT05227547
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Collaborators: Henri Mondor University Hospital, Institut National de la Santé Et de la Recherche Médicale, France
Conditions Chronic Obstructive Lung Disease, Chronic Obstructive Pulmonary Disease
Enrollment 186 participants
Start Date 2022-10-05
Primary Completion 2030-10-05 (estimated)
Study Completion 2030-10-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-02